Can the risk of skin cancer after transplantation be reduced by mTOR inhibitors?

American Journal of Kidney Diseases

Volumn 61, Issue 5, 2013, Pages 698-700

  Carroll, Robert P ^a   Chapman, Jeremy R ^b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; RAPAMYCIN; TACROLIMUS;

ACNE; ADVERSE OUTCOME; APHTHOUS ULCER; ARTICLE; CANCER MORTALITY; CANCER RISK; DOSE RESPONSE; EDEMA; HUMAN; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; METASTASIS; PNEUMONIA; SKIN CARCINOMA;

EID: 84876281176     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.12.007     Document Type: Editorial

References (11)

1. J.M. Campistol, J. Eris, R. Oberbauer Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation J Am Soc Nephrol 17 2 2006 581 589
2. J. Dantal, M. Hourmant, D. Cantarovich Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens Lancet 351 9103 1998 623 628
3. S. Euvrard, E. Morelon, L. Rostaing Sirolimus and secondary skin-cancer prevention in kidney transplantation N Engl J Med 367 4 2012 329 339
4. S.B. Campbell, R. Walker, S.S. Tai, Q. Jiang, G.R. Russ Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer Am J Transplant 12 5 2012 1146 1156
5. Van Den Akher J, Harden PN, Hoitsma AJ, Proby C, Wolterbeek R, Bowes Bavinck JN, DeFitjer JH. A 2-year randomised controlled trial converting stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus. J Clin Oncol., in press.
6. H. Ekberg, C. Bernasconi, H. Tedesco-Silva Calcineurin inhibitor minimization in the SYMPHONY study: observational results 3 years after transplantation Am J Transplant 9 8 2009 1876 1885
7. J.C. Martinez, C.C. Otley, T. Stasko Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study Arch Dermatol 139 3 2003 301 306
8. C.C. Otley, B.M. Coldiron, T. Stasko, G.D. Goldman Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants Arch Dermatol 137 4 2001 459 463
9. K.D. Brantsch, C. Meisner, B. Schonfisch Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study Lancet Oncol 9 8 2008 713 720
10. R.P. Carroll, H.M. Ramsay, A.A. Fryer, C.M. Hawley, D.L. Nicol, P.N. Harden Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia Am J Kidney Dis 41 3 2003 676 683
11. T. Jirakulaporn, B. Endrizzi, B. Lindgren, J. Mathew, P.K. Lee, A.Z. Dudek Capecitabine for skin cancer prevention in solid organ transplant recipients Clin Transplant 25 4 2011 541 548